Insider Transactions in Q2 2024 at Adc Therapeutics Sa (ADCT)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2024
|
Robert Azelby Director |
SELL
Open market or private sale
|
Direct |
6,995
-11.66%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Viviane Monges Director |
SELL
Open market or private sale
|
Direct |
1,437
-1.33%
|
$2,874
$2.89 P/Share
|
|
Jun 17
2024
|
Peter Hug Director |
SELL
Open market or private sale
|
Direct |
1,193
-0.65%
|
$2,386
$2.89 P/Share
|
|
Jun 17
2024
|
Jean Pierre Bizzari Director |
SELL
Open market or private sale
|
Direct |
6,995
-8.09%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Ron Squarer Director |
SELL
Open market or private sale
|
Direct |
6,995
-7.98%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Victor Sandor Director |
SELL
Open market or private sale
|
Direct |
6,995
-7.96%
|
$13,990
$2.89 P/Share
|
|
Jun 17
2024
|
Thomas Pfisterer Director |
SELL
Open market or private sale
|
Direct |
1,437
-0.67%
|
$2,874
$2.89 P/Share
|
|
Jun 13
2024
|
Robert Azelby Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+40.0%
|
-
|
|
Jun 13
2024
|
Peter Hug Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+17.87%
|
-
|
|
Jun 13
2024
|
Jean Pierre Bizzari Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.62%
|
-
|
|
Jun 13
2024
|
Thomas Pfisterer Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+15.67%
|
-
|
|
Jun 13
2024
|
Victor Sandor Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.28%
|
-
|
|
Jun 13
2024
|
Ron Squarer Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+31.33%
|
-
|
|
Jun 13
2024
|
Viviane Monges Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+27.02%
|
-
|
|
May 07
2024
|
Ameet Mallik Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
29,731
-2.48%
|
$118,924
$4.48 P/Share
|